跳转至内容
Merck
CN

M2319

甲氟喹 盐酸盐

≥98% (HPLC), Cx36 and Cx50 blocker, powder

别名:

(AS)-rel-a-(2R)-2-哌啶基-2,8-双(三氟甲基)-4-喹啉甲醇单盐酸盐

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C17H17ClF6N2O
化学文摘社编号:
分子量:
414.77
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352202
EC Number:
257-412-0
MDL number:
Assay:
≥98% (HPLC)
Form:
powder
Quality level:
Storage condition:
desiccated
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

甲氟喹 盐酸盐, ≥98% (HPLC), powder

InChI

1S/C17H16F6N2O.ClH/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11;/h3-5,8,12,15,24,26H,1-2,6-7H2;1H/t12-,15+;/m1./s1

InChI key

WESWYMRNZNDGBX-YLCXCWDSSA-N

SMILES string

Cl[H].[H][C@@]1(CCCCN1)[C@@H](O)c2cc(nc3c(cccc23)C(F)(F)F)C(F)(F)F

assay

≥98% (HPLC)

form

powder

storage condition

desiccated

color

white

solubility

DMSO: soluble 38 mg/mL
H2O: insoluble

Quality Level

正在寻找类似产品? 访问 产品对比指南

Application

使用盐酸甲氟喹:
  • 基于不同剂量治疗耳蜗器官型培养物,以评估其在细胞凋亡相关细胞通路中的作用
  • 筛选体外抗血吸虫活性
  • 用于胶质母细胞瘤细胞的毒性分析

Biochem/physiol Actions

甲氟喹被广泛用作抗疟疾药物。它抑制疟原虫的80S核糖体。它有很多副作用,例如焦虑、头晕、颤抖、头痛和听觉损失。甲氟喹会通过细胞凋亡损伤耳蜗和前庭毛细胞。它还会损害螺旋神经节神经元、退化皮质神经元并且破坏神经元钙稳态。
间隙连接通道Cx36和Cx50的阻断剂。

pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Acute Tox. 4 Oral

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Sophie Zaloumis et al.
Malaria journal, 11, 303-303 (2012-08-31)
Mechanistic within-host models relating blood anti-malarial drug concentrations with the parasite-time profile help in assessing dosing schedules and partner drugs for new anti-malarial treatments. A comprehensive simulation study to assess the utility of a stage-specific pharmacokinetic-pharmacodynamic (PK-PD) model for predicting
Regulation of hypoxia-induced autophagy in glioblastoma involves ATG9A
Rahim SAA, et al.
British Journal of Cancer, 117(6), 813-813 (2017)
Chanaki Amaratunga et al.
The Lancet. Infectious diseases, 12(11), 851-858 (2012-09-04)
Artemisinin-resistant Plasmodium falciparum has been reported in Pailin, western Cambodia, detected as a slow parasite clearance rate in vivo. Emergence of this phenotype in western Thailand and possibly elsewhere threatens to compromise the effectiveness of all artemisinin-based combination therapies. Parasite
Identification of plumbagin and sanguinarine as effective chemotherapeutic agents for treatment of schistosomiasis
Zhang SM and Coultas KA
International Journal for Parasitology, Drugs and Drug Resistance, 3(11), 28-34 (2013)
Mahadeo A Sukhai et al.
The Journal of clinical investigation, 123(1), 315-328 (2012-12-04)
Despite efforts to understand and treat acute myeloid leukemia (AML), there remains a need for more comprehensive therapies to prevent AML-associated relapses. To identify new therapeutic strategies for AML, we screened a library of on- and off-patent drugs and identified

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持